Antibody engineering know-how

Antibody engineering know-how
Credit: IgG and engineered recombinant antibody fragments

(Medical Xpress)—Antibodies are of enormous value to society as therapeutic and diagnostic agents. There are many scientists worldwide interested in producing their own novel engineered antibody based molecules as part of their research work.

Scientists from UCD Conway Institute and UCD Centre have published an accessible instruction manual detailing how to make antigen binding molecules for molecular studies and translational research.

This protocol published in the journal Nature Protocols describes the design and development of recombinant antigen-binding molecules from through rapid identification and cloning of variable genes.

Describing the work, Conway scientist Dr David O'Connell said, "The protocol is accessible for groups not specialised in this area, and allows them to carry out reverse engineering of functional, recombinant antigen-binding molecules from hybridomas within 50 working days.

We are delighted with this publication and view it an endorsement by a prestigious scientific journal of our experience in the engineering of . It reflects our capabilities in antibody design, construction and characterisation that are made possible through the excellent infrastructure available on the university campus."

This research reflects a successful collaboration between UCD scientists with CRO Genscript Inc. The team, which also includes Conway Fellow, Professor Gil Lee hopes to attract new collaborators with both industry and academia on foot of this work.

More information: Nat Protoc. 2013 May 16;8(6):1125-48. doi: 10.1038/nprot.2013.057. Epub 2013 May 16.

Related Stories

New stable antibodies created

Jun 29, 2012

(Medical Xpress) -- Australian scientists have overcome one of the most pressing problems facing the pharmaceutical industry – how to create antibodies that are stable enough to meet stringent requirements necessary ...

Reducing experimental inflammatory arthritis

May 24, 2013

(Medical Xpress)—UCD researchers led by Conway Fellow, Professor David Brayden in UCD School of Veterinary Medicine have successfully reduced inflammation in the swollen arthritic knees of a murine model using a novel nanoparticle.

Setting standards for protein localisation

May 09, 2013

(Phys.org) —In order to understand how cells work, scientists first need to establish where every single protein in the cell resides. In the largest study of its kind to date, the two most widely used microscopy-based ...

Recommended for you

Growing a blood vessel in a week

1 hour ago

The technology for creating new tissues from stem cells has taken a giant leap forward. Three tablespoons of blood are all that is needed to grow a brand new blood vessel in just seven days. This is shown ...

Testing time for stem cells

4 hours ago

DefiniGEN is one of the first commercial opportunities to arise from Cambridge's expertise in stem cell research. Here, we look at some of the fundamental research that enables it to supply liver and pancreatic ...

Team finds key signaling pathway in cause of preeclampsia

23 hours ago

A team of researchers led by a Wayne State University School of Medicine associate professor of obstetrics and gynecology has published findings that provide novel insight into the cause of preeclampsia, the leading cause ...

Rapid test to diagnose severe sepsis

Oct 23, 2014

A new test, developed by University of British Columbia researchers, could help physicians predict within an hour if a patient will develop severe sepsis so they can begin treatment immediately.

User comments